- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Osteochondroma in Belgium
Total 383 results
-
Hasselt UniversityUnknownMultiple Sclerosis | Paralytic StrokeBelgium, Netherlands
-
Wellspect HealthCareTerminatedMultiple Sclerosis | Bladder DysfunctionBelgium, Netherlands, Germany, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenWithdrawnHematologic Diseases | Multiple MyelomaBelgium
-
Radboud University Medical CenterIpsenCompletedLiver Diseases | Polycystic Kidney, Autosomal Dominant | Hepatomegaly | Polycystic Liver DiseaseNetherlands, Belgium
-
Commissie Voor Klinisch Toegepast OnderzoekUnknownMultiple Myeloma and Plasma Cell NeoplasmNetherlands, Belgium
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingPoland, Belgium, Turkey, Bulgaria, United States, Czechia, Germany, Kuwait, Latvia, Lebanon
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedA Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple MyelomaMultiple MyelomaBelgium, France, Germany
-
National MS Center MelsbroekCompleted
-
Marie D'hoogheCompleted
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingPoland, Turkey, United States, Latvia, Lebanon, Germany, Belgium, Bulgaria, Czechia, Kuwait
-
Boston Scientific CorporationTerminatedRelapsing Remitting Multiple SclerosisSpain, Germany, Belgium, Poland, France, Russian Federation
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Germany, Belgium
-
University Hospital, AntwerpUnknownAcute Myeloid Leukemia | Multiple Myeloma | Chronic Myeloid LeukemiaBelgium
-
SanofiGenzyme, a Sanofi CompanyCompletedMultiple MyelomaSweden, Estonia, Belgium, Lithuania
-
University Hospital, AntwerpUniversity Hospital, GhentRecruitingMarfan Syndrome | FBN1 MutationBelgium
-
European Organisation for Research and Treatment...UnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmFrance, Belgium, Netherlands, Germany, Italy
-
Universitair Ziekenhuis BrusselUnknownSleep DisorderBelgium
-
Janssen Research & Development, LLCCompletedMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell NeoplasmUnited States, Belgium, Russian Federation
-
SanofiCompletedMultiple SclerosisBelgium, Germany, Netherlands
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknownObesity | Healthy Volunteers | Prader-Willi Syndrome | Muscle Hypotonia | Hypotonia-Cystinuria Syndrome | Dwarfism, Growth Hormone DeficiencyBelgium
-
GlaxoSmithKlineCompletedMultiple SclerosisBelgium, Sweden, Czech Republic, Denmark, Norway
-
University Hospital, ToulouseEpidemiological and Clinical Research Information Network; International Clinical...CompletedPrader-Willi SyndromeFrance, Belgium, Germany
-
Hellenic Institute for the Study of SepsisEuropean CommissionCompletedPneumonia | Sepsis | Mortality | Biomarkers | Respiratory Distress Syndrome | Multiple Organ Failure | Gram-Negative Bacteria InfectionGreece, Belgium
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
BayerCompletedMultiple SclerosisTurkey, Czechia, Hungary, Israel, Germany, France, Belgium, Greece, Netherlands, Egypt, Kazakhstan, Argentina, Portugal, Algeria, Saudi Arabia, Albania, Tunisia
-
BayerCompletedMultiple SclerosisSwitzerland, Poland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Slovenia, Israel, Belgium, Denmark, Netherlands, Canada, Norway, Finland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Czech Republic, France, Italy, Mexico, South Africa, United Kingdom, Germany, Poland, Romania, Ukraine, Netherlands, Austria, Canada, Israel, New Zealand, Slovakia, Greece, Serbia, India, Belgium, Switzerland, ... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
Daren K. HeylandFresenius KabiCompletedSepsis | Critical Illness | Multiple Organ FailureUnited States, Canada, Belgium, Switzerland, Germany
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
BiogenCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States, Bulgaria, Belgium, Poland, Lithuania, Kuwait, Turkey
-
CelgeneCompletedRelapsing Multiple SclerosisSerbia, United States, Poland, Spain, Belgium, Bulgaria, Georgia, Greece, Romania, Russian Federation, Ukraine, Hungary, Italy
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
BioCeryxUniversity of British Columbia; University College London Hospitals; Brugmann... and other collaboratorsUnknownTrisomy 21 and Other Fetal AneuploidyAustralia, United Kingdom, Spain, Canada, Belgium, Portugal
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
MedDay Pharmaceuticals SATerminatedMultiple SclerosisUnited States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden